Skip to content

A novel abdominal wall entry suction device to increase Veress needle safety: a prospective pilot study

A novel abdominal wall entry suction device to increase Veress needle safety: a prospective pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00017639
Enrollment
12
Registered
2019-07-24
Start date
2016-07-06
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Investigation of a new suction device for abdominal wall entry

Interventions

Group 1: This is a single-arm study, with a crossover design in which patients receive a CT-scan with and without AWESD (abdominal wall entry suction device) application.

Sponsors

Rijnstate Hospital, Arnhem, The Netherlands
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients aged 18 years and above that are physically fit without known abdominal pathologies, nor prior large abdominal surgeries are eligible for inclusion.Potentially eligible participants that require abdominal CT-examination for any reason are recruited from the Department of Radiology (Rijnstate Hospital, Arnhem, The Netherlands). However, those without a prior abdominal CT-scan or a prior scan older than 6 months are excluded because these scans serve as control. Nevertheless, in participants that require multiple scans (e.g. blank and arterial phase), the AWESD will be applied during one scan, whereas the second acquisition, without device, serves as control. Written informed consent is obtained from all participants upon inclusion.

Exclusion criteria

Exclusion criteria: Patients with a subcutaneous thickness > 8 centimeters are excluded as their subcutis approximated the AWESD’s height. In this situation it is assumed that only subcutaneous fat will be drawn into device; subsequently, losing the hypothesized peritoneal lifting power. Patients in an emergency setting, alongside pregnant or breast-feeding women are also excluded.

Design outcomes

Primary

MeasureTime frame
The difference in distance from the linea alba to the intestines, vena cava and abdominal aorta between CT-scans with and without AWESD application. These differences will be measured after acquisition of both CT-scans (with and without AWESD application).

Countries

Netherlands

Contacts

Public ContactJean Daemen

Rijnstate Hospital, Arnhem, The Netherlands

jean.daemen@icloud.com0031(0)880058888

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026